Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Jan 26, 2021; 9(3): 632-638
Published online Jan 26, 2021. doi: 10.12998/wjcc.v9.i3.632
Table 1 Scores of clinical assessments before and after intervention and at 4-wk follow-up

FMA-LE (total score)
BBS (total score)
TUGT (s)
Pre-treatment18 (34)39 (56)34.1
Post-treatment18 (34)43 (56)27.1
Follow-up 18 (34)45 (56)27.5
Table 2 Plantar pressure distributions in percentage measured on days 1 (baseline/pretreatment), 4, 7, 11, 14 (posttreatment), and 28 (follow-up) on the affected side and unaffected side
Toes area
Metatarsal area
Midfoot area
Heel area
Affected
Unaffected
Affected
Unaffected
Affected
Unaffected
Affected
Unaffected
Day 0106.9216.9340.636.4711.4376.140.77
Day 04012.9825.0647.629.049.4264.4830.96
Day 076.157.6736.5549.743.8211.7653.6632.35
Day 117.716.7533.1750.138.1514.8451.3229.02
Day 1412.94.9230.842.436.879.2348.5942.46
Day 2811.755.2722.0253.7215.911.7150.3228.52
Table 3 Gait spatial-temporal parameters and symmetric index before and after intervention and at 4-wk follow-up
Mean velocity (%height/s)Cadence (steps/min)Symmetric index (SI, %)
SIStride (%height)
SICadence
Pre-treatment16.9573.60125.12193.31
Post-treatment18.2181.20126.74193.85
Follow-up18.3976.40122.40193.69
Table 4 Mean root-mean-square values (μv) over the gait cycle computed for the tibialis anterior, gastrocnemius lateralis, and gastrocnemius medialis of the affected and unaffected lower limbs before and after intervention and at 4-wk
TA
GL
GM
Symmetric index (SI, %)

Affected
Unaffected
Affected
Unaffected
Affected
Unaffected
SITA
SIGL
SIGM
Stance phase
Pre-treatment9.9575.7822.5372.8311.9648.20153.58105.49120.48
Post-treatment19.4677.7425.9546.8519.0041.24119.9257.4273.84
Follow-up25.5455.8523.0558.3820.4143.2474.4886.7771.74
Swing phase
Pre-treatment8.1188.4020.2752.739.9341.19166.3988.93122.30
Post-treatment20.7367.4322.1234.6017.9627.23105.9444.0141.03
Follow-up36.3873.6621.7433.1818.9730.2667.7641.6645.87